
Revive Therapeutics
CSE: RVV | OTC: RVVTF
Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly.
Revive Therapeutics
$0.135
Latest News
Revive Therapeutics Ltd. Expands Life Offering to Quebec
December 15, 2022
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
December 1, 2022